İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2022 · article

RESEARCH BURDEN OF INTERSTITIAL LUNG DISEASES IN TURKEY-RBILD

YÖKSİS OpenAlex Açık erişim · green
Yıl2022
Atıf3OpenAlex
Yüzdelik%60,3
FWCI0,411,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q4

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıSARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
  • Katalog eşleşmesi (ISSN)Sarcoidosis Vasculitis and Diffuse Lung Diseases
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Introduction: The aim of our study is to investigate the etiological distribution of ILD in Turkey by stratifying the epidemiological characteristics of ILD cases, and the direct cost of initial diagnosis of the diagnosed patients. Material-Method: The study was conducted as a multicenter, prospective, cross-sectional, clinical observation study. Patients over the age of 18 and who accepted to participate to the study were included and evaluated as considered to be ILD. The findings of diagnosis, examination and treatment carried out by the centers in accordance with routine diagnostic procedures were recorded observationally. Results: In total,1070 patients were included in this study. 567 (53%) of the patients were male and 503 (47%) were female. The most frequently diagnosed disease was IPF (30.5%). Dyspnea (75.9%) was the highest incidence among the presenting symptoms. Physical examination found bibasilar inspiratory crackles in 56.2 % and radiological findings included reticular opacities and interlobular septal thickenings in 55.9 % of the cases. It was observed that clinical and radiological findings were used most frequently (74.9%) as a diagnostic tool. While the most common treatment approaches were the use of systemic steroids and antifibrotic drugs with a rate of 30.7% and 85.6%, respectively. The total median cost from the patient's admission to diagnosis was 540 Turkish Lira. Conclusion: We believe that our findings compared with data from other countries will be useful in showing the current situation of ILD in our country to discuss this problem and making plans for a solution.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

3atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 3 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2025 Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life Study.Atıf 1 · OpenAlex
  2. 2025 Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life StudyAtıf 1 · OpenAlex
  3. 2025 Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life StudyAtıf 1 · OpenAlex

Yazarlar

30
  1. OLCAY AYÇİÇEK 1
  2. ERDOĞAN ÇETİNKAYA 2
  3. FATMA DEMİRCİ ÜÇSULAR 3
  4. NAZAN BAYRAM GAZİANTEP ÜNİVERSİTESİ 4
  5. ABDURRAHMAN ŞENYİĞİT 5
  6. NİMET AKSEL 6
  7. NURHAN ATİLLA 7
  8. NURHAN SARIOĞLU BALIKESİR ÜNİVERSİTESİ 8
  9. ELİF YELDA NİKSARLIOĞLU 9
  10. AHMET ILGAZ 10
  11. TALAT KILIÇ 11
  12. ŞULE ÇİLEKAR 12
  13. AYDANUR EKİCİ 13
  14. SİBEL ARINÇ 14
  15. HACI AHMET BİRCAN 15
  16. DİLDAR DUMAN 16
  17. ÖZLEM ŞENGÖREN DİKİŞ 17
  18. ONUR YAZICI 18
  19. ABDULLAH KANSU 19
  20. NURİ TATAR 20
  21. SERDAR BERK 21
  22. YELDA VAROL 22
  23. AHMET EMİN ERBAYCU 23
  24. BÜNYAMİN SERTOĞULLARINDAN 24
  25. ALİ KADRİ ÇIRAK 25
  26. MUSTAFA ÇÖRTÜK 26
  27. GÜLİSTAN KARADENİZ 27
  28. ALPER ŞİMŞEK 28
  29. CENGİZHAN SEZGİ 29
  30. FUAT EREL BALIKESİR ÜNİVERSİTESİ 30